Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02668315

Recruitment Status : Completed

First Posted : January 29, 2016

Last Update Posted : August 5, 2019

Sponsor:

Collaborators:

Canadian Cancer Society Research Institute (CCSRI)

Canadian Institutes of Health Research (CIHR)

Hopital de l'Enfant-Jesus

Vancouver General Hospital

St. Justine's Hospital

Stem Cell Network (SCN)

Information provided by (Responsible Party):

Sandra Cohen, Maisonneuve-Rosemont Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 2018
Actual Study Completion Date :	August 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Cohen S, Roy J, Lachance S, Delisle JS, Marinier A, Busque L, Roy DC, Barabé F, Ahmad I, Bambace N, Bernard L, Kiss T, Bouchard P, Caudrelier P, Landais S, Larochelle F, Chagraoui J, Lehnertz B, Corneau S, Tomellini E, van Kampen JJA, Cornelissen JJ, Dumont-Lagacé M, Tanguay M, Li Q, Lemieux S, Zandstra PW, Sauvageau G. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. Lancet Haematol. 2019 Nov 5. pii: S2352-3026(19)30202-9. doi: 10.1016/S2352-3026(19)30202-9. [Epub ahead of print]

To Top